Skip to main content

Revance Therapeutics, Inc. (NASDAQ: RVNC) Investor Securities Class Action Lawsuit 01/03/2025

  • If you purchased a significant amount of shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) between February 29, 2024 and December 6, 2024, and / or if you purchased anyNASDAQ: RVNC shares prior to February 2024 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: March 4, 2025. NASDAQ: RVNC investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

January 03, 2025 - An investor in shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) filed a lawsuit in the U.S. District Court for the Middle District of Tennessee over alleged violations of Federal Securities Laws by Revance Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between February 29, 2024 and December 6, 2024. Nashville, TN base...



You must register (for free) or login to view the entire case.